Method development and validation of six bile acids for regulated bioanalysis: improving selectivity and sensitivity.

BACKGROUND Quantification of bile acids using LC-MS has previously been very challenging on triple quadrupole MS systems due to the absence of a primary fragment ion for unconjugated bile acids. RESULTS A LC-high-resolution/accurate mass MS method for the analysis of six bile acids (cholic acid, chenodeoxycholic acid, taurocholic acid, deoxycholic acid, lithocholic acid and ursodeoxycholic acid) was developed and successfully validated. The method includes a single extraction and a single injection with all analytes separated using target-selected ion monitoring (SIM) mode in two periods with a resolution of 70,000 and 140,000, respectively. CONCLUSION This is the first LC-high-resolution/accurate mass assay fully validated to quantify six bile acids for regulated bioanalysis.

[1]  S. Scalia.  Bile acid separation. , 1995, Journal of chromatography. B, Biomedical applications.

[2]  Jean W Lee,et al.  Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics. , 2009, Bioanalysis.

[3]  A. Roda,et al.  High-performance liquid chromatographic-electrospray mass spectrometric analysis of bile acids in biological fluids. , 1995, Journal of chromatography. B, Biomedical applications.

[4]  H. J. Brink,et al.  Rapid and quantitative analysis of unconjugated C(27) bile acids in plasma and blood samples by tandem mass spectrometry. , 2001, Journal of lipid research.

[5]  B. Casetta,et al.  Quantitative Analysis of Bile Acids in Human Plasma by Liquid Chromatography-Electrospray Tandem Mass Spectrometry: A Simple and Rapid One-Step Method , 2003, Clinical chemistry and laboratory medicine.

[6]  C. Vestal,et al.  Thermospray ionization liquid chromatography-mass spectrometry: a new and highly specific technique for the analysis of bile acids. , 1989, Journal of lipid research.

[7]  E. de Hoffmann,et al.  Bile acids and conjugates identified in metabolic disorders by fast atom bombardment and tandem mass spectrometry. , 1991, Clinical chemistry.

[8]  Roger Hayes,et al.  Recommendations on biomarker bioanalytical method validation by GCC. , 2012, Bioanalysis.

[9]  C. Klaassen,et al.  Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  A. Batta,et al.  Gas chromatography of bile acids. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[11]  A. Roda,et al.  Separation techniques for bile salts analysis. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[12]  P. Clayton,et al.  Plasma bile acids in patients with peroxisomal dysfunction syndromes: analysis by capillary gas chromatography — mass spectrometry , 1987, European Journal of Pediatrics.

[13]  Walter A. Korfmacher,et al.  High-resolution mass spectrometry will dramatically change our drug-discovery bioanalysis procedures. , 2011, Bioanalysis.

[14]  Bertrand Rochat,et al.  The future key role of LC-high-resolution-MS analyses in clinical laboratories: a focus on quantification. , 2012, Bioanalysis.

[15]  G. Schmitz,et al.  Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  Y. Alnouti,et al.  Simultaneous characterization of bile acids and their sulfate metabolites in mouse liver, plasma, bile, and urine using LC-MS/MS. , 2011, Journal of pharmaceutical and biomedical analysis.

[17]  Sean Yu,et al.  Quantitation of small molecules using high-resolution accurate mass spectrometers - a different approach for analysis of biological samples. , 2009, Rapid communications in mass spectrometry : RCM.

[18]  Fabio Garofolo,et al.  Bioanalytical Method Validation , 2004 .

[19]  Xingrong Liu,et al.  High-throughput liquid chromatography/mass spectrometry method for the quantitation of small molecules using accurate mass technologies in supporting discovery drug screening. , 2013, Rapid communications in mass spectrometry : RCM.

[20]  A. von Eckardstein,et al.  Quantification of the 15 major human bile acids and their precursor 7α-hydroxy-4-cholesten-3-one in serum by liquid chromatography-tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[21]  F. Moldovan,et al.  Significant differences between arterial and venous endothelin-like immunoreactivity in human plasma. , 1991, Clinical chemistry.

[22]  William J Griffiths,et al.  Bile acids: analysis in biological fluids and tissues , 2010, Journal of Lipid Research.

[23]  A Kaufmann,et al.  Comprehensive comparison of liquid chromatography selectivity as provided by two types of liquid chromatography detectors (high resolution mass spectrometry and tandem mass spectrometry): "where is the crossover point?". , 2010, Analytica chimica acta.